Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities

被引:0
作者
Christian Gunadi
Yuyan Shi
机构
[1] University of California San Diego,Herbert Wertheim School of Public Health and Human Longevity Science
来源
BMC Public Health | / 23卷
关键词
Health policy/regulation; Substance abuse; Observational data/quasi-experiment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 101 条
  • [1] Gossop M(1996)Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings BMJ 313 1299-308
  • [2] Griffiths P(1994)Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow‐up study Addiction 89 2613-20
  • [3] Powis B(2008)Patterns of abuse among unintentional pharmaceutical overdose fatalities JAMA 300 461-8
  • [4] Williamson S(2021)Provider compliance with Kentucky’s prescription drug monitoring program’s mandate to query patient opioid history: study examines Kentucky’s prescription drug monitoring program which features a mandatory patient history query requirement for providers filling opioid prescriptions Health Aff 40 504-26
  • [5] Strang J(2018)Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse Amer J Health Econ 4 34-47
  • [6] Oppenheimer E(2014)What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose Drug Alcohol Depend 145 44-53
  • [7] Tobutt C(2016)State legal restrictions and prescription-opioid use among disabled adults N Engl J Med 375 1550-1556
  • [8] Taylor C(2019)Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use Health Aff 38 77-112
  • [9] Andrew T(2018)The effect of prescription drug monitoring programs on opioid utilization in Medicare Amer Econ J Econ Policy 10 274-276
  • [10] Hall AJ(2021)Prescription drug monitoring program mandates and opioids dispensed following emergency department encounters for patients with sickle cell disease or cancer with bone metastasis JAMA 326 348-354